Compare · head to head
Daewon Pharmaceutical vs PharmGen Science
PharmGen Science ranks higher overall — 360 rank 74 vs 46.
Daewon Pharmaceutical leads on Quality (59 vs 54) and Sentiment (59 vs 41). PharmGen Science leads on Safety (73 vs 22). The two are close on Value.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Small |
| ISIN | KR7003220001 | KR7004720009 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 46 | 74 |
| Value | 55 | 57 |
| Quality | 59 | 54 |
| Growth | 51 | NR |
| Safety | 22 | 73 |
| Sentiment | 59 | 41 |
| Quality details | ||
| Profitability | 64 | 70 |
| Cash Truth | 53 | 38 |
Daewon Pharmaceutical vs Towa PharmaceuticalDaewon Pharmaceutical vs Reyon PharmaceuticalDaewon Pharmaceutical vs Il Dong PharmaceuticalDaewon Pharmaceutical vs Rohto PharmaceuticalAdd a third stock →
Full analyses: Daewon Pharmaceutical · PharmGen Science
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100